Kidney Status and Events Preceding Death in Heart Failure: A Real-world Nationwide Study

Deewa Zahir Anjum,Caroline Hartwell Garred,Nicholas Carlson,Emil L. Fosbøl,Mariam Elmegaard Malik,Pardeep S. Jhund,John JV McMurray,Mark C. Petrie,Lars Køber,Morten Schou

DOI: https://doi.org/10.1101/2024.10.15.24315570

2024-10-16

Abstract:Background: Chronic kidney disease (CKD) is a frequent comorbidity in heart failure (HF) patients, affecting prognosis and mortality. This study investigates the relationship between kidney function and adverse kidney events preceding death in HF patients. Methods: We analyzed registry data of HF patients who died between 2014 and 2021, with at least one year of HF diagnosis. Adverse kidney events, including acute kidney injury (AKI) and end-stage kidney disease (ESKD), were assessed. Patients were grouped by estimated glomerular filtration rate (eGFR) one year before death: eGFR-60, eGFR 30-59, and eGFR<30. Results: Among 36,435 HF patients who died, 37% had eGFR-60, 46% had eGFR 30-59, and 17% had eGFR<30 one year before death. Median age was 81 years, and 61.2% were men. Adverse kidney events occurred in 13.1% of patients. AKI was inversely related to kidney function, affecting 6.5% (95% confidence interval 6.1-6.9) of those with eGFR-60, 7.0% (6.6.-7.4) with eGFR 30-59, and 21.9% (20.9-22.9) with eGFR<30. ESKD occurred in 0.7%(0.6-0.9), 2.6% (2.4-2.8), and 35.5% (34.3-36.7) of patients in the respective eGFR categories. In the last three months before death, kidney function notably declined, with increased chronic kidney replacement therapy. Factors associated with higher adverse kidney events included younger age, male sex, in-hospital death, and greater frailty. Conclusions: In HF patients, AKI and ESKD are common in the last year of life, particularly in those with lower baseline eGFR, with kidney decline accelerating in the final months.

Cardiovascular Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the relationship between renal insufficiency and adverse renal events prior to death in patients with heart failure (HF). Specifically, the study focuses on the incidences of acute kidney injury (AKI) and end - stage kidney disease (ESKD) in the last year of life of patients with heart failure, especially in those patients with a lower baseline estimated glomerular filtration rate (eGFR). The study also explores the accelerated occurrence of these adverse renal events in the last few months of life and the related factors that may lead to these events, such as age, gender, in - hospital death, and the degree of frailty.

Through this study, the authors hope to increase the attention to renal complications in patients with heart failure and promote the development of early intervention strategies to improve the prognosis of patients. In addition, the research results may be helpful for clinical trial design, enabling it to better include those patients with severe renal insufficiency, thereby enhancing the applicability of the research results.